Complementary assays are required to comprehensively map complex biological entities such as genomes, proteomes and interactome networks. However, how various assays can be optimally combined to approach completeness while maintaining high precision often remains unclear.
of interactions, combining them should significantly increase overall detection.
In order to comprehensively map binary PPIs both at the scale of signaling pathways and protein complexes and at the scale of whole proteomes, it should thus be possible to establish an optimal combination of assays and/or assay versions to capture nearly all interactions in a defined search space while ensuring high specificity ( Fig. 1a) . Our goal here was to systematically analyze experimental variables that influence binary PPI detection across multiple assays and integrate such knowledge into the rational design of a framework that maximizes detection with a minimal number of assays.
We evaluated a class of binary PPI assays that are based on exogenously expressing pairs of hybrid proteins, collectively referred to as Tag1-X and Tag2-Y, where X and Y can be any protein, and Tag1 and Tag2 are two polypeptidic moieties, the physical proximity of which can be readily monitored.
For example, in the Y2H system, X and Y interacting proteins restore physical proximity between the DNA binding domain (DB) and the activation domain (AD) of a transcription factor upon exogenous expression of DB-X and AD-Y hybrid proteins 21, 30 .
In addition to assessing different assays defined by specific tag pairs, we also evaluated assay version differences due to: i) the relative orientation or swap of the tested proteins X and Y, differentiating between Tag1-X/Tag2-Y and Tag1-Y/Tag2-X; ii) the tagging configurations where we distinguish protein fusions from either the N-or C-terminal extremities of X and Y, e.g. Tag1-X/Tag2-Y versus X-Tag1/Y-Tag2; and iii) the exogenous expression systems, either in yeast, in mammalian cells, or in vitro (cell-free) (Fig. 1b) .
To uniformly compare these different experimental conditions within a single assay, we have engineered a PPI detection technology based on the functional reconstitution of NanoLuc, a small 19kDa, high-performance bioluminescent protein 31 . Using this NanoLuc two-hybrid (N2H) system in combination with highly versatile vectors capable of driving protein expression as N-or C-terminal fusions of assay tags in all three environments, we show that permuting various experimental conditions in a single assay can achieve similar PPI detection as through the continuous addition of fundamentally different techniques (Fig. 1c) . Our results suggest that only a few versatile assays should be sufficient to achieve near saturation with maximal precision in medium-and high-throughput proteome-scale PPI mapping projects. This finding might also be of value for large-scale mapping of other complex biological landscapes.
RESULTS

Combining binary PPI assays under maximized specificity
Different binary PPI assays often detect distinct subsets of interactions 23 , thus combining several assays should increase the overall recovery in a given search space of the proteome (Fig. 1a) . However, what remains unclear is how binary PPI assay combinations affect the overall specificity, i.e. the fraction 6 of true interactions detected in a given search space over the fraction of spurious pairs reported.
Ten years ago, our group introduced an empirical framework to benchmark binary PPI assays based on: i) a list of ~100 well-documented positive control PPIs, constituting the first version of a PRS, or hsPRS-v1, ii) a list of ~100 pairs of proteins randomly picked among the ~2x10 8 pairwise combinations of human proteins, constituting version 1 of a RRS, or hsRRS-v1 22 ; and iii) the Gateway cloning of all open reading frames (ORFs) involved, allowing identical constructs to be used across many different assays 33 . We and others have since cross-examined the following binary PPI assays against each other: i) Y2H 23 , ii) yellow fluorescent protein-protein complementation assay (YFP-PCA) 23 , iii) mammalian protein-protein interaction trap (MAPPIT) 23 , iv) well-based nucleic acid programmable protein arrays (wNAPPA) 23 , v) luminescence-based mammalian interactome (LUMIER) 23 , vi) kinase substrate sensor (KISS) 25 , vii) Gaussia princeps complementation assay (GPCA) 24, 34 , viii) dual luminescence-based co-immunoprecipitation (DULIP) 26 , and ix) bioluminescence-based two-hybrid (LuTHy) 27 , combining bioluminescence resonance energy transfer (LuTHy-BRET) and luminescence-based co-precipitation (LuTHy-LuC) assays ( Fig. 1c, left panel) .
Under the various conditions used in these studies, each of the corresponding 10 assays, representing the union of only one or two version(s) ( Supplementary Table 1 ), recovered between 21% and 39% of hsPRS-v1 pairs, with the negative control hsRRS-v1 detection ranging between 0% and 4% ( Supplementary Fig. 1a ). However, to directly compare the different assays side-by-side and combine them homogeneously, an identical RRS threshold should be applied to each individual assay. After applying an identical RRS cutoff, increasing from 1% to 10%, to each of the above-mentioned assays, we observed that the union of the ten different assays detected between 70% and 91% of positive control hsPRS-v1 pairs with 8% and 59% of random hsRRS-v1 pairs scoring positive, respectively ( Supplementary Fig. 1b) . Therefore, to avoid accumulation of random pairs affecting the quality of 7 future analyses, each assay should be calibrated such that none of the RRS pairs are scored positive.
After reanalyzing published data under these conditions, the recovered fractions of hsPRS-v1 pairs ranged from 3% to 33% for individual assays performed in only one or two version(s) ( Fig. 2a) , while the cumulative detection reached 65% when all assays were combined ( Fig. 2b and Supplementary   Fig. 1c ). This suggested that many different assays, each associated to specific tag pairs and plasmids, would be needed to reach full coverage.
Benchmarking binary PPI assays and assay versions
We considered the possibility that the failure of the 10 assays described above ( Fig. 2a,b ) to detect nearly all PRS interactions might be due to ORF clone quality issues and/or problematic interaction annotations. To avoid such possibilities, we re-examined all protein pairs from the original reference sets: hsPRS-v1 and hsRRS-v1 23 . As a first step, only fully sequence-verified, full length clonal ORFs were isolated (Supplementary Fig. 2a ). Resulting pairs were then filtered based on updated literature information and annotations for binary PPIs ( Supplementary Table 2 ). Finally, 60 PRS and 78 RRS pairs were assembled into a second-generation of reference sets: hsPRS-v2 and hsRRS-v2, respectively (see Methods for details and Supplementary Fig. 2b ). After repeating four assays that were originally benchmarked against hsPRS-v1 and hsRRS-v1 with the second generation of reference sets, the cumulative PRS recovery rate reached 50% and 58% with -v1 and -v2 sets respectively, when none of the RRS pairs were scored positive ( Supplementary Fig. 2c ).
As the failure of 10 well-established assays to detect nearly all binary PPIs did not arise from problems with the original reference sets, we decided to evaluate whether expanding the number of experimental conditions, or assay versions ( Fig. 1b) , covered by any single technique could increase its coverage and ultimately reduce the number of assays required. To investigate this, we benchmarked 8 several versions of Y2H, MAPPIT, KISS and GPCA against the second-generation of reference sets, hsPRS-v2 and hsRRS-v2. These four assays and corresponding versions (10 in total) were implemented as summarized in Supplementary Table 1 . In particular, we constructed Gateway-compatible vectors for GPCA to cover all four possibilities of tagging configurations with this assay, i.e. Tag1-X/Tag2-Y, X-Tag1/Tag2-Y, Tag1-X/Y-Tag2 and X-Tag1/Y-Tag2 or, simply, N1N2, C1N2, N1C2 and C1C2, respectively. Between 8% and 37% of hsPRS-v2 pairs were detected by the 10 versions of GPCA, MAPPIT, KISS and Y2H when none of the hsRRS-v2 pairs were scored positive ( Fig. 2c) , which represented an average PRS detection rate of 22.8% ± 8.8% (S.D.) ( Fig. 2c , shaded blue area).
When we considered all protein pairs identified by the union of these 10 versions corresponding to four assays, the hsPRS-v2 recovery rate reached 63% ( Fig. 2d and Supplementary Fig. 2d ), similar to what was obtained by combining ten distinct assays, performed in only one or two version(s), as published in the literature (65%; Fig. 2b ). This result demonstrates that the combination of four distinct assays exploring different experimental conditions can recover as many PPIs as 10 fundamentally different techniques limited to a few versions.
Towards developing a highly versatile binary PPI assay
In an attempt to further minimize the overall number of multi-version assays required to maximize binary PPI detection and, by extension, reduce the associated cloning efforts and lab resources, we decided to develop a highly versatile binary PPI detection system opening access to all assay versions defined by the three experimental parameters presented in Fig. 1b .
Although after re-analyzing published data 1.3-fold and 1.4-fold increases in PRS detection were observed when switching from one orientation to the other (i.e. Tag1-X/Tag2-Y to Tag1-Y/Tag2-X), or from one configuration to another (i.e. N1N2 to C1N2), respectively ( Supplementary Fig. 3a,b) , the 9 impact of permuting expression systems remained unclear as no assay had been used to systematically explore this parameter. However, several high quality PPI datasets have been obtained using heterologous expression of protein pairs in yeast 12, 35 , in mammalian cells 36,37 and via cell-free coupled transcription-translation systems in vitro 38, 39 .
After surveying existing binary interaction assays, it appeared that split-protein reconstitution was the most suitable technology to cover the three experimental parameters presented in Fig. 1b .
Indeed, compared to other binary PPI methods involving cell-specific responses or antibody-based captures, split protein-based assays enable detection of PPIs through the simple reassembly of a functional reporter protein ( Fig. 1c) . Among the different reporters available today, NanoLuc, a highlystable 19kDa protein derived from the luciferase complex of the deep-sea shrimp O. gracilirostris, is gaining increasing attention for the development of binary PPI detection assays, as highlighted by recent publications 31, 32, 40, 41 . Following the single-step addition of imidazopyrazinone substrates, NanoLuc instantly produces an intense and sustainable glow-type luminescence with a specific activity about 100fold greater than that of other luciferases, allowing its detection in vitro as well as in living cells and animals 31, 42, 43 . Therefore, split-NanoLuc-based technology appears to be the ideal candidate for the highthroughput detection of binary PPIs in various experimental conditions. Among the recent studies reporting a split-NanoLuc binary PPI assay, only one extensively fragmented the enzyme to test different tag pairs in an unbiased way ( Supplementary Table 3 ) 32 . After selecting a cleavage site between amino acids 156 and 157, the authors heavily modified the corresponding fragments to reduce their association affinity. The resulting moieties, 11S (156 amino acids) and 114 (11 amino acids), were then used to develop the NanoLuc Binary Technology (NanoBiT) assay 32 .
Even though NanoBiT was originally designed for expression of protein pairs in mammalian 10 cells, we decided to evaluate whether fragments 11S and 114 could be used to further develop our new, highly versatile binary PPI detection system ( Fig. 1c , right panel). To investigate this, we first adapted the available NanoBiT vectors with the reported original split site 32 to achieve different tagging configurations with Gateway cloning compatibility and then benchmarked all four pairing combinations, i.e. N1N2, C1N2, N1C2 and C1C2, against hsPRS-v2 and hsRRS-v2. The benchmarking of these four NanoBiT versions in conditions where none of the hsRRS-v2 pairs are scored positive showed that between 3% and 25% of hsPRS-v2 pairs could be recovered (Fig. 2c) . These results revealed optimal performances when the larger NanoBiT fragment, 11S (156 amino acids), was fused to the C-terminal extremity of the tested proteins, as demonstrated by PRS recovery rates of 22% and 25% for the C1N2 and C1C2 configurations, respectively, similar to those from four other well-established assays ( Fig.   2c ). These observations were in agreement with the author's original assumption that the C-terminus tagging of proteins with 11S might impose minimal steric constraints 32 .
Nanoluc 2-Hybrid (N2H): a highly versatile binary PPI assay
Although NanoBiT appears to be a powerful tool to study PPI kinetics in live cells, the comprehensive benchmarking of this assay revealed two underperforming versions, N1N2 and N1C2, that might be associated to the inherent properties of the selected tag pair 32 . Therefore, we decided to empirically define a new split site for NanoLuc in an unbiased way. To do this, we first extensively fragmented the full-length enzyme by transposon-based insertional mutagenesis ( Supplementary Fig.   4a ). Complementation of the resulting fragments, F1 and F2 (58 pairs in total), was then systematically tested using a proximity assay in vitro ( Supplementary Fig. 4b) , and a cleavage site between amino acids 65 and 66 was selected ( Fig. 3a) to build the NanoLuc 2-hybrid (N2H) assay ( Fig. 1c, right panel and Supplementary Fig. 4c ). 11 In order to comprehensively cover the experimental parameters presented in Fig. 1b with the single N2H assay, we constructed four Gateway-compatible plasmids from which N2H fragments, F1 (amino acids 1-65) and F2 (amino acids 66-171), can be expressed as either N-or C-terminal fusions of any pair of proteins X and Y in yeast, in mammalian cells or in vitro (cell-free). To drive expression in all three environments with each individual plasmid, we engineered a tripartite promoter of ~1kb that can easily be introduced into any vector of interest (Fig. 3b) . The performance of this 3-in-1 promoter was evaluated by measuring the expression of full-length and fragmented NanoLuc in yeast (yN2H), in mammalian cells (mN2H) and in vitro (vN2H). We obtained intense signals ranging between 10 8 and 10 9 relative luminescence units (RLU) when the full-length NanoLuc was expressed in each individual environment. Furthermore, compared to the full-length enzyme, individually expressed NanoLuc fragments did not produce any significant signal. More importantly, the two fragments expressed together did not generate any strong self-assembly luminescence that could interfere with the accurate measurement of binary PPIs. Taken together, these results demonstrate the full functionality of both the tripartite promoter and the selected pair of NanoLuc fragments (Fig. 3b) .
By combining NanoLuc fragments with the tripartite promoter and Gateway-cloning technology into four uniform expression vectors (pDEST-N2H-N1, -N2, -C1 and -C2), all 24 assay versions (4x3x2) presented in Fig. 1b could thus be implemented with the single N2H assay. The Gatewaycompatibility of N2H destination plasmids also renders the entire human ORFeome collection of over 18,000 entry clones 44 directly amenable to this assay.
As N2H was the first binary PPI detection tool in which proteins could be expressed as either Nor C-terminal fusions of protein tags in yeast (yN2H), in mammalian cells (mN2H) or in vitro (vN2H) from the same Gateway-compatible destination vector ( Figs. 1b,c, 3b) , it was important to benchmark the robustness of PPI-mediated readouts in each of the three environments. Using hsPRS-v2 and hsRRS-v2 pairs, we compared bioluminescence signals between two independently replicated experiments in yN2H, mN2H and vN2H. As highlighted by the R 2 >0.97, a robust reproducibility was observed in each case when all 138 pairs from hsPRS-v2 and hsRRS-v2 were tested. In addition, a large dynamic range of luminescence readout between 10 2 and 10 7 RLU was consistently observed in each environment ( Fig.   3c ).
To compare the performance of N2H assay versions in detecting reference binary PPIs over random protein pairs, we normalized luminescence signals and separated hsPRS-v2 from hsRRS-v2. No major differences were observed in the overall luminescence ratios as a fraction of PRS pairs always generated higher signals than that from random pairs in each case ( Fig. 3d) . As observed for C1C2-mN2H or C1C2-yN2H, for example, the only differences in PRS detection rates between assay versions came from one or a few RRS pairs that generated higher luminescence signals than the average. These version-specific artifacts ultimately reduced the fraction of PRS pairs recovered as their corresponding thresholds of no RRS pair scoring positive increased (Fig. 3d) . The same observation was also made for well-established assays ( Fig. 2a,c) . Thus, in conditions where none of the RRS pairs are scored positive (threshold displayed for each individual version in Fig. 3d ), the 12 tested N2H assay versions detected between 7% and 32% of hsPRS-v2 pairs ( Fig. 3e) , demonstrating similar performances compared to five other PPI detection methods ( Fig. 2c ) that averaged 20.4% ± 9.9% (S.D.) PRS recovery ( Fig. 3e , shaded blue area). When these 12 N2H versions were combined, a PRS detection of 60% was yielded ( Fig. 3f and Supplementary Fig. 5a ), similar to the 65% obtained by combining either 10 different, versionlimited assays from the literature [23] [24] [25] [26] [27] [28] (Fig. 2a,b ) or five non-N2H, multi-version assays ( Fig. 2c and Supplementary Fig. 5b) .
These results highlight the advantages of using a single, highly versatile PPI detection tool, such as N2H, to reduce the overall cloning efforts and lab resources ( Fig. 4a-c) , as the same set of expression 13 vectors are used to explore several assay versions at a time ( Fig. 4d) whilst recovering as many PPIs as a combination of many different techniques (Fig. 4e) . The published assays in Fig. 4 are presented in Fig.   2a and Supplementary Table 1 .
Combining multi-version assays to maximize PPI detection
With all assays in hand to systematically evaluate the impact of the three variables presented in As the impact of permuting proteins X and Y from one tag to the other (Tag1-X:Tag2-Y versus Tag1-Y:Tag2-X) had already been comprehensively investigated by six different assays in the literature 23, 26, 27 ( Supplementary Table 1 ), we only repeated Y2H and MAPPIT to explore this parameter. While a single, randomly picked orientation yielded PRS recovery rates of 19% and 32%, switching to the second orientation increased detection to 25% and 40% for Y2H and MAPPIT, respectively. Importantly, cumulative PPI detection increased from 38% to 47% when a single or two orientations were combined for both assays, respectively ( Fig. 5a ). This 1.2-fold (47/38) increase was consistent with our analysis of published results 23, 26, 27 (Supplementary Fig. 3a ) and confirmed that permuting the orientation of tested proteins is a valuable option to increase PPI detection.
To probe the influence of different tagging configurations on PPI detection, i.e. the N-or Cterminal positioning of the assay tags, we systematically evaluated the contribution of each pairing combination (N1N2, C1N2, N1C2 and C1C2) with KISS, NanoBiT, GPCA, mN2H, yN2H and vN2H.
For KISS, the analysis was restricted to the two published configurations: N1N2 and C1N2 25 . Using mN2H as a first example, we observed an average PRS detection rate of 19% for a single, randomly 14 picked tagging configuration ( Fig. 5b) . When two of the four possible tagging configurations were used, the PRS recovery rate was further increased to 28%. Finally, when three and all four tagging configurations were combined, 34% and 37% of hsPRS-v2 pairs were identified ( Fig. 5b) . Thus, using more than one tagging configuration substantially increased the detection of binary PPIs by mN2H.
Similar observations were made for the other assays as the PRS recovery rates were increased from an average 26% to 42% for KISS, where only two configurations were tested, and from 14% to 28% for NanoBiT, 19% to 35% for GPCA, 21% to 45% for yN2H and 19% to 33% for vN2H when only one or all four configurations were tested, respectively. The same trend was observed when combining all tested versions and a 1.6-fold increase in PRS detection obtained by extending assays from a single to multiple configurations ( Fig. 5b, union) . These results illustrate the gain of sensitivity achieved when performing the same assay with different combinations of tagging configurations, and confirm the preliminary observations made after re-analyzing published data 23, 25 (Supplementary Fig. 3b ).
To evaluate the impact of different protein expression systems on binary PPI detection, we implemented different versions of the N2H assay in yeast, in mammalian cells and in vitro (cell-free).
All four tagging configurations ( Fig. 1b,c) were systematically tested in each environment. For the N1N2 version, an average PRS detection rate of 24% was reached when performing the assay in a single environment. This recovery was increased to 35% when switching to a second expression environment.
Finally, after combining detected PRS pairs from all three environments, the cumulative recovery rate reached 42% for the N1N2 versions of N2H ( Fig. 5c ). When we expanded the analysis to the other tagging configurations, N1C2, C1C2, and C1N2, we consistently observed that performing the assay with different expression systems allowed the identification of a larger fraction of PPIs ( Fig. 5c ). Indeed, a robust growth of cumulative PRS detection was observed for N1C2 (from 18% to 40%), C1C2 (from 11% to 22%) and C1N2 (from 24% to 43%) when PPIs were tested in just one or all three different expression environments, respectively. Importantly, the cumulative PPI recovery rate for all 12 N2H assay versions tested here was increased from 38% to 60% when using one or all three expression systems, respectively, which represented an overall 1.6-fold increase in PPI detection ( Fig. 5c, union) .
This result also highlights that the performance of the single multi-version N2H assay (60% PRS recovery) was significantly higher than that of any other method presented in this study ( Fig. 2a,c) .
Taken together, these observations demonstrate the benefit of permuting experimental conditions in binary PPI assays to increase detection ( Fig. 5a-c) . What remained unclear was the overall complementarity of assay versions when they are all combined. To visualize the different subsets of interactions recovered by the six different assays analyzed in this study ( Figs. 2c, 3e) , we displayed the performance of their corresponding 26 assay versions in the form of a checkerboard plot. Under conditions where none of the hsRRS-v2 pairs are scored positive, the different versions detected distinct but partially overlapping subsets of PPIs, the union of which reached 78% ( Fig. 6 ). Importantly, as already observed in Fig. 3f , the combination of 12 N2H versions detected 60% of PRS pairs, which means that this single assay recovered over three-quarters of all PPIs detected in this study ( Fig. 6) .
Taken together, these results showed that a single assay exploring multiple dimensions of the parameter space ( Fig. 1b,c) will be sufficient to map a large fraction of binary PPIs in a defined search space.
DISCUSSION
Over the past ten years, the community has continuously released new binary PPI detection tools.
The benchmarking of these assays, using a first generation of positive (hsPRS-v1) and random (hsRRS-v1) reference sets, revealed that they often identify distinct subsets of interactions 23 . Therefore, a combination of multiple techniques will be required to increase overall PPI detection and reach completeness ( Fig. 1a) . Under conditions of optimal specificity, we have shown that no single PPI assay is exceptionally superior to any other, including the most recently developed technologies. Furthermore, we have established that instead of continuously developing fundamentally different techniques, it should be possible to reach completeness by assembling a minimal number of binary PPI assays, as long as different experimental conditions, or assay versions, can be implemented for each selected assay ( Figs. 1b,c) .
We eliminated the possibility that the failure of 10 combined assays to detect about a third of known interactions in the original hsPRSv1 came from ORF clone quality issues or problematic interaction annotations by benchmarking assays against an improved, unbiased 22 second-generation of reference sets: hsPRS-v2 and hsRRS-v2. Although the improvement of reference sets was purely focused on pair quality in this study, the next generation of PRS and RRS should include larger fractions of interactions such as those involved in higher order complex structures as well as interactions from cocomplex crystal structures where direct contacts are well defined. Protein pairs for which a variety of K D measurements are available 27 will also be included to characterize assays and assay versions according to their capabilities of recovering interactions of different strengths.
Using the improved standards under conditions that maximized specificity, we have shown that considering three experimental parameters, i.e. protein orientation, tagging configuration and expression system ( Fig. 1b) , for assay development is a valuable option to increase PPI detection. In particular, we demonstrated that combining a relatively small number of assays exploring these parameters could lead to a PPI detection rate of up to 78%. In this context, we showed that combining 12 different versions of N2H, a new, highly versatile split NanoLuc-based assay, could recover 60% of all positive control interactions, similar to the 65% recovery rates obtained by combining either 10 published versionlimited assays or four distinct multi-version assays. This means that the highly versatile N2H assay identified 77% of all PPIs detected in this study. In short, our results highlight the advantage of N2H or similar versatile systems, capable of handling several experimental parameters in a single, multi-version toolkit, to improve PPI detection and ultimately reduce the number of binary PPI assays required. This also suggests that only a few versatile binary PPI assays will be sufficient to reach complete coverage of any defined search space.
Surprisingly, 22% of hsPRS-v2 pairs remained undetected after combining the six assays tested in this study, even though all interactions had similar numbers of experimental evidence and publications ( Supplementary Fig. 6 ). We examined whether there was any correlation between a tested PPI assay in this study, and the original detection method 54 of the PRS pairs, but we did not find any correlation between these two elements. In two cases, the ORFs we used corresponded to shorter isoforms that did not contain reported interaction domains ( Supplementary Table 5 ). Upon removal of these two ORFs, the PRS recovery rate by the union of all 26 assay versions yields 81%. However, two thirds of undetected hsPRS-v2 pairs contained reported interaction domains. Therefore, to reach completeness, we suggest that future assay development should be focused on expanding the number of versions covered by already-existing techniques. In that regard, we have extended our finding to the recently developed LuTHy assay 27 Given the difficulties of performing heterogeneous PPI assays with the necessity of preparing different clones for expression vectors and setting up different experiments, performing an equal number of N2H assay versions to acquire comparable PPI detection offers a valuable alternative to reduce these efforts ( Fig. 4a-e ). 18 The fact that expression environment has a strong impact on PPI detection is particularly interesting as it can easily be tuned with N2H or similar versatile assays. For example, protein pairs could be expressed in multiple cell lines, including distinct cell types and tissue origins, while a range of pH or salt concentrations could easily be tested when performing the assay in vitro. From a single set of plasmids, this would open access to almost unlimited assay versions to generate near-complete, highquality binary interactome maps in a more time-effective manner.
METHODS
Processing publicly available hsPRS-v1 and hsRRS-v1 data. Publicly available protein interaction
datasets used in this study came from the original publications 23, 24, 26 or were provided by the authors upon request 25, 27 . Analyses were restricted to datasets for which a straightforward titration at a threshold of no RRS pair scoring positive could be applied. To evaluate the recovery rates of hsPRS-v1 when none of the RRS pairs are scored positive, data were calibrated such that the provided score for a given PRS pair must be strictly higher than the highest score of any of the RRS pairs. When authors clearly identified a particular pair as not interacting (negative) in their experiments, this assignment was also considered to generate the final dataset at a threshold where no RRS pair was scored positive. The same criterion was applied to evaluate the fractions of pairs found with available assay permutations, by using the highest RRS score found in each independent version of the corresponding assay.
Construction of hsPRS-v2 and hsRRS-v2 reference sets. Second-generation hsPRS-v2 (60 pairs) and
hsRRS-v2 (78 pairs) were constructed from pre-existing hsPRS-v1 (92 pairs) and hsRRS-v1 (92 pairs) 23 .
To update the v1 sets generated over 10 years ago, we first decided to obtain single colony isolates for each ORF clone, removing all possible mutations that could have appeared in the original mini-pool ORFeome collection 11, 45 . Each entry clone passed through multiple rounds of individual single colony 19 isolations, plasmid DNA purifications, and Sanger DNA sequencings, and only full-length, fully sequence-verified clones (next generation sequencing) were selected. By comparing the ORF sequences with genome annotations, we removed ORFs that did not match annotations in Gencode 27 46 , resulting in 76 PRS pairs and 78 RRS pairs (91.8% success rate at the ORF level, Supplementary Fig. 2a ). We further inspected the remaining 76 PRS pairs by literature mining and informatics filtering. We revisited the supporting evidence for each PRS pair using an updated classification of binary PPI detection methods (Supplementary Data 1). For example, pull down and co-immunoprecipitation are no longer considered as binary PPI detection methods 12 . Ten PRS pairs not satisfying binary classification were removed. Three PRS pairs containing HLA proteins were also discarded, as no reference ORF could be defined. Finally, three PRS pairs between precursor ligands (FGF1, CXCL1, and TNFSF10) and their respective receptors were also removed due to the requirement of proteolytic cleavages of the ligands for maturation ( Supplementary Table 2 and Supplementary Fig. 2b ). After applying these filters, at total of 60 PRS pairs and 78 RRS pairs were thus assembled into hsPRS-v2 and hsRRS-v2, respectively (Supplementary Table 4 ). Discarded pairs from hsPRS-v1 and hsRRS-v1 are presented in Supplementary Data 1, and PubMed IDs supporting remaining hsPRS-v2 pairs are presented in Supplementary Data 2. The performances of the updated reference sets were compared to the older sets by repeating four assays previously benchmarked with hsPRS-v1 and hsRRS-v1 ( Supplementary Fig.   2c ).
Cloning ORFs into Gateway-compatible expression plasmids. Human hsPRS-v2 and hsRRS-v2
ORFs are available in pDONR221 or pDONR223 vectors, which make them compatible with the Gateway cloning technology. Each ORF was introduced into the different assay-specific expression vectors used in this study via an LR clonase-mediated Gateway reaction (Life Technologies). LR 20 reaction products were subsequently transformed into DH5α competent bacterial cells and grown for 24 hours in ampicillin-containing TFB liquid medium. Plasmid DNA was extracted using a NucleoSpin 96
Plasmid kit from Macherey-Nagel. After PCR-amplification using plasmid-specific primers, the size of each DNA amplicon was examined by agarose gel electrophoresis. For each batch of ready-to-go destination vectors, DNA sequencing was performed on a subset of the cloned samples to check the quality of cloning before running the PPI assays.
Construction of the tripartite promoter and N2H plasmids. The design of the 3-in-1 hybrid promoter was based on the recent description of highly potent, minimal synthetic promoters in yeast S. cerevisiae 47 . These promoters comprise a short synthetic upstream activating sequence (UAS) and generic core elements, including a TATA box and a Transcription Start Site (TSS). The average distance separating the UAS motif upstream of the TATA box in native yeast and mammalian cell promoters was sufficient to insert the GC boxes and the CCAAT box-binding transcription factor (CTF) binding site of the herpes simplex virus-thymidine kinase (HSV-TK) promoter 48 between these two elements. To boost expression levels in mammalian cells, the cytomegalovirus (CMV) immediate early enhancer was inserted upstream of the yeast synthetic UAS. To drive expression in vitro using a coupled transcription/translation system, a T7 promoter was inserted 30 nucleotides downstream of the TATA box, immediately followed by a cricket paralysis virus internal ribosome entry site (CrPV-IRES), a versatile IRES used to initiate translation in both, mammalian and yeast cells 49, 50 . All these regulatory elements were assembled using gene synthesis (GenScript) and 40 nucleotides of sequence homology to the insertion sites in the vector backbone (pESC-LEU, Agilent, cat #217452; pESC-TRP, Agilent, cat #217453) were added for gap repair recombination in yeast 51, 52 . NanoLuc fragments, F1 (1-65) and F2 (66-171), were linked to either the N-terminal (pDEST-N2H-N1, -N2) or C-terminal (pDEST-N2H-C1,
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-C2) extremity of the tested protein, using a flexible hinge encoding a polypeptide of 20 amino acids along with Gateway recombinational cloning sites. Finally, expression levels in the different systems were assessed using full length or fragmented NanoLuc (Promega, cat #N1001) reporter genes (Fig. 3b) .
Systematic evaluation of NanoLuc fragments complementation. NanoLuc fragments, were systematically generated by transposon-based insertional mutagenesis randomly distributed between nucleotides 55 and 249 of the NanoLuc coding sequence, corresponding to amino acid residues 19 and 83, respectively (Supplementary Fig. 4a ). Resulting moieties were characterized by Sanger DNA sequencing using pMOD forward and reverse primers according to the manufacturer's protocol (EZ-Tn5, epicentre-Illumina, #TNP10622). Each fragment was then subcloned into a specifically designed SNAP-Tag in vitro expression vector, using Gateway recombination cloning (Life Technologies). They were expressed using a human IVT in vitro system and their complementation was assessed using a proximity-based assay.
Design of the SNAP-Tag in vitro expression vector. DNA encoding the SNAP-Tag was PCRamplified from the pSNAPf vector (NEBs, #N9183S) to be inserted in frame into the pT7CFE1-CHis plasmid provided in the human IVT kit (ThermoFisher, #88882). The Gateway cloning cassette was introduced immediately after the SNAP tag sequence using the Gateway vector conversion system (Invitrogen, # 11828-029). All subsequent cloning steps were performed using Gateway BP and LR reactions according to the manufacturer's protocol. DNA constructs were prepared using standard maxiand mini-prep protocols.
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Human IVT in vitro expression system. To assess complementation of NanoLuc fragments, a HeLa cell lysate was used for in vitro-coupled transcription and translation (IVT system, ThermoFisher, #88882). All the reactions were performed according to the manufacturer's protocol, except for DNA concentrations (150 ng for both expression vectors were used) and the use of a 5x dilution of the HeLa by the maximum luminescence value from one of the two controls (X-empty or empty-Y), as summarized in equation (1) below 25 .
To identify protein pairs that score positive at a threshold of no RRS detection, two criteria were considered: 1) NLR PRS > NLR HIGHEST RRS , and 2) NLR PRS > 1.0. All PRS pairs that did not meet these two criteria were not scored and therefore defined as not detectable in the corresponding assay version.
The same analysis and criteria were applied for both KISS and MAPPIT assays.
For GPCA and NanoBiT experiments, a PRS pair was scored positive if its corresponding raw luminescence signal (from the average of three independent experiments) was strictly higher than the RRS pair having the highest raw luminescence signal (from the average of three independent experiments).
For Y2H assay, diploid yeast cells containing both, DB-X/Y bait and AD-Y/X prey plasmids, were spotted in quadruplicate on selective medium supplemented with 3-AT (SC-LWH, 3-AT). After titration of 3-AT, a minimal concentration of 1 mM was selected as no RRS pairs were detected for this 31 specific threshold 12 . In parallel, diploid yeast cells containing DB-X/Y bait and AD-empty prey vectors were also used to identify bait proteins that are auto-activators of the HIS3 selection marker. After 6 days of culture, yeast growth was visually determined and scored from "0" (no growth) to "4" (strong growth) for both the DB-X/Y:AD-Y/X and DB-X/Y:AD-empty combinations. If the growth score was >0 for the DB-X/Y:AD-Y/X combination in at least two of the three experiments performed and was superior by at least 2 units to the one of DB-X/Y:AD-empty combination, a protein pair was scored positive.
Construction of cumulative recovery plots.
To plot the fraction of interaction recovered for n number of assays or assay versions, the recovery rate for each of the possible n combinations was calculated first (Supplementary Figs. 1c, 2d, 5a ) and then averaged (Figs. 2b,d, 3f and Supplementary Fig. 5b) . The error bars in Figs. 2b,d, 3f and Supplementary Fig. 5b indicate the standard deviation of the average.
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Figure 4 | Invested resources for various combinations of binary PPI assays and PRS detection
rates. Numbers of individual components required to achieve maximal PRS detections are indicated for different combinations of assays and assay versions. PRS recovery rates presented in Fig. 4e correspond to those found in Fig. 2b (published) , Supplementary Fig. 5b (non-N2H) and Fig. 3f (N2H) . Except for Y2H-N1C2, Y2H-C1C2 and Y2H-C1N2 for which unambiguous titrations could not be obtained from the original study 28 , all published assay versions benchmarked against hsPRS-v1 and hsRRS-v1 were used ( Fig. 2a, Supplementary Table 1 ). Supplementary Table 4 . 
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